Ventilator-associated Pneumonia
📧 Sign up to get email alerts when something new happens for Ventilator-associated Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers. [NA]
A completed clinical trial evaluated the efficacy of piperacillin-tazobactam as empirical therapy for ventilator-associated pneumonia in ESB…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Daily Chlorexidine Bath for Health Care Associated Infection Prevention [Phase 3]
A Phase 3 trial evaluated daily chlorhexidine gluconate baths to prevent health care-associated infections, including ventilator-associated …
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Usage of Procalcitonin to Reduce Antibiotics Duration in VAP in Neurosurgical ICU [NA]
A clinical trial update describes assessing procalcitonin-guided antibiotic duration to treat ventilation-associated pneumonia in a neurosur…
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Copeptin: Disease Severity Indicator [NA]
A completed clinical trial evaluated copeptin as a biomarker for disease severity in patients with lower respiratory tract infections, inclu…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. [Phase 3]
Phase 3 study evaluating aztreonam-avibactam ± metronidazole versus meropenem ± colistin for serious Gram-negative infections, including com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics [Phase 4]
Phase 4 clinical trial evaluating rapid diagnostic-guided use of ceftazidime-avibactam for bloodstream infections and ventilator-associated …
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Defining Antibiotic Treatment Duration for Ventilator - Associated Lung Infection [Phase 3]
Phase 3 trial update on antibiotic treatment duration for ventilator-associated pneumonia, completed.
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: Oro-nasal Decontamination to Prevent Ventilator-associated Pneumonia [Phase 2, Phase 3]
Clinical trial update on oro-nasal decontamination to prevent ventilator-associated pneumonia, including Phase 2 and Phase 3 results.
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients [Phase 3]
Phase 3 trial update on selective decontamination of the digestive tract in ICU patients with critical illness and sepsis.
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016) [Phase 3]
Phase 3 trial MK-7655A-016 comparing Imipenem/Cilastatin/Relebactam to Piperacillin/Tazobactam in hospital-acquired and ventilator-associate…
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Duration of Antibiotic Treatment for Early VAP (DATE) Trial [NA]
Clinical trial update for the DATE trial evaluating duration of antibiotic treatment in early ventilator-associated pneumonia has completed …
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: GRam Stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) Trial [Phase 4]
A Phase 4 trial update on GRam Stain-guided Antibiotics Choice for Ventilator-Associated Pneumonia (GRACE-VAP) completed.
-
CLINICAL_TRIALS trial_result · 2022-02-28Clinical Trial Update: Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease [Phase 1, Phase 2]
A safety-focused clinical trial update on nebulized BromAc® therapy for COVID-19-related respiratory conditions across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: Effect of Statin Therapy on Mortality in Patients With Ventilator Associated Pneumonia [Phase 4]
Phase 4 trial investigating whether statin therapy affects mortality in patients with ventilator-associated pneumonia.
-
CLINICAL_TRIALS trial_result · 2021-08-18Clinical Trial Update: Addition of Tobramycin Inhalation in the Treatment of Ventilator Associated Pneumonia [Phase 4]
Phase 4 trial investigating addition of tobramycin inhalation for treating ventilator-associated pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: Nebulized Aztreonam for Prevention of Gram Negative Ventilator-associated Pneumonia [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating nebulized aztreonam to prevent gram-negative ventilator-associated pneumonia has been terminated.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: PROPHY-VAP: Prevention of Early Ventilation Acquired Pneumonia (VAP) in Brain Injured Patients by a Single Dose of Ceftriaxone [Phase 3]
A Phase 3 trial evaluating a single-dose ceftriaxone to prevent early ventilation-acquired pneumonia in brain-injured patients has completed…
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment [Phase 2]
Phase 2 trial investigating Candida in respiratory secretions of critically ill patients and the efficacy of antifungal treatment; study ter…
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: VITAL - VAP Prevention by BIP (Bactiguard Infection Protection) ETT Evac in Belgian ICUs [Phase 4]
Phase 4 trial update on Bactiguard ETT Evac device for preventing ventilator-associated pneumonia in Belgian ICUs.
-
CLINICAL_TRIALS trial_result · 2021-01-19Clinical Trial Update: Effect of Angulus on Patient-elevation Compliance [NA]
Clinical trial completed investigating Angulus and its impact on patient-elevation compliance in ventilated patients; results posted in 2021…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens [Phase 3]
Phase 3 trial evaluating Cefiderocol (S-649266) versus best available therapy for severe infections due to carbapenem-resistant Gram-negativ…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial [Phase 4]
Phase 4 trial evaluating probiotics to prevent severe pneumonia and endotracheal colonization in ventilated patients; trial completed.
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens [Phase 3]
Phase 3 clinical trial of Cefiderocol for healthcare-associated pneumonia and hospital-acquired pneumonia has completed with results posted …
-
CLINICAL_TRIALS trial_result · 2020-07-13Clinical Trial Update: Low Versus High Corticosteroid Use in Ventilator Associated Pneumonia [Phase 2]
Phase 2 trial comparing low versus high corticosteroid use in ventilator-associated pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-01Clinical Trial Update: Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia [Phase 2]
Phase 2 clinical trial exploring umbilical cord-derived mesenchymal stem cells for viral pneumonia due to a novel coronavirus; current statu…